Japan Tissue Engineering Co., Ltd. (7774.T)
JPY 457.0
(-2.35%)
JPY 457.0
(-2.35%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 143.16 Million JPY | 119.63% |
| 2022 | -729.31 Million JPY | -46.48% |
| 2021 | -497.88 Million JPY | -6.7% |
| 2020 | -466.62 Million JPY | -62.53% |
| 2019 | -287.09 Million JPY | 13.85% |
| 2018 | -333.24 Million JPY | -246.23% |
| 2017 | 227.89 Million JPY | -17.5% |
| 2016 | 276.24 Million JPY | 140.53% |
| 2015 | -681.53 Million JPY | 1.3% |
| 2014 | -690.52 Million JPY | 16.59% |
| 2013 | -827.83 Million JPY | 23.18% |
| 2012 | -1.07 Billion JPY | 1.7% |
| 2011 | -1.09 Billion JPY | 5.24% |
| 2010 | -1.15 Billion JPY | -5.19% |
| 2009 | -1.09 Billion JPY | 3.0% |
| 2008 | -1.13 Billion JPY | -4.4% |
| 2007 | -1.08 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -211.13 Million JPY | -207.31% |
| 2024 Q2 | -14.17 Million JPY | 93.29% |
| 2023 Q1 | 13.83 Million JPY | 113.35% |
| 2023 Q2 | -25.47 Million JPY | -284.07% |
| 2023 FY | 143.16 Million JPY | 119.63% |
| 2023 Q3 | -41.94 Million JPY | -64.7% |
| 2023 Q4 | 196.75 Million JPY | 569.03% |
| 2022 FY | -729.31 Million JPY | -46.48% |
| 2022 Q1 | -268.2 Million JPY | -70.52% |
| 2022 Q2 | -153.18 Million JPY | 42.89% |
| 2022 Q3 | -204.25 Million JPY | -33.34% |
| 2022 Q4 | -103.66 Million JPY | 49.25% |
| 2021 Q2 | -138.09 Million JPY | -6.65% |
| 2021 FY | -497.88 Million JPY | -6.7% |
| 2021 Q1 | -129.47 Million JPY | -129.22% |
| 2021 Q3 | -73.03 Million JPY | 47.12% |
| 2021 Q4 | -157.28 Million JPY | -115.37% |
| 2020 Q3 | -137.85 Million JPY | -41.53% |
| 2020 Q2 | -97.4 Million JPY | 44.3% |
| 2020 Q1 | -174.87 Million JPY | -330.87% |
| 2020 FY | -466.62 Million JPY | -62.53% |
| 2020 Q4 | -56.48 Million JPY | 59.02% |
| 2019 FY | -287.09 Million JPY | 13.85% |
| 2019 Q3 | -91.73 Million JPY | -5.87% |
| 2019 Q2 | -86.64 Million JPY | 53.02% |
| 2019 Q1 | -184.45 Million JPY | -221.17% |
| 2019 Q4 | 75.74 Million JPY | 182.57% |
| 2018 Q3 | -70.2 Million JPY | -382.02% |
| 2018 FY | -333.24 Million JPY | -246.23% |
| 2018 Q1 | -440.16 Million JPY | -462.08% |
| 2018 Q2 | 24.89 Million JPY | 105.66% |
| 2018 Q4 | 152.23 Million JPY | 316.85% |
| 2017 Q3 | 39.29 Million JPY | -38.15% |
| 2017 Q2 | 63.53 Million JPY | 1719.47% |
| 2017 FY | 227.89 Million JPY | -17.5% |
| 2017 Q1 | 3.49 Million JPY | -99.27% |
| 2017 Q4 | 121.56 Million JPY | 209.36% |
| 2016 FY | 276.24 Million JPY | 140.53% |
| 2016 Q4 | 479.84 Million JPY | 1339.24% |
| 2016 Q3 | -38.72 Million JPY | 7.62% |
| 2016 Q2 | -41.91 Million JPY | 65.91% |
| 2016 Q1 | -122.96 Million JPY | -425.97% |
| 2015 Q2 | -204 Million JPY | 13.66% |
| 2015 Q3 | -278.97 Million JPY | -36.75% |
| 2015 Q4 | 37.72 Million JPY | 113.52% |
| 2015 FY | -681.53 Million JPY | 1.3% |
| 2015 Q1 | -236.28 Million JPY | -446.38% |
| 2014 Q2 | -317 Million JPY | -48.27% |
| 2014 Q4 | 68.21 Million JPY | 129.93% |
| 2014 FY | -690.52 Million JPY | 16.59% |
| 2014 Q1 | -213.8 Million JPY | -183.29% |
| 2014 Q3 | -227.92 Million JPY | 28.1% |
| 2013 Q3 | -255.64 Million JPY | 5.81% |
| 2013 Q1 | -225.3 Million JPY | 7.91% |
| 2013 FY | -827.83 Million JPY | 23.18% |
| 2013 Q4 | -75.47 Million JPY | 70.48% |
| 2013 Q2 | -271.41 Million JPY | -20.46% |
| 2012 Q1 | -306.72 Million JPY | -24.21% |
| 2012 FY | -1.07 Billion JPY | 1.7% |
| 2012 Q4 | -244.67 Million JPY | 12.94% |
| 2012 Q3 | -281.04 Million JPY | -14.6% |
| 2012 Q2 | -245.23 Million JPY | 20.05% |
| 2011 FY | -1.09 Billion JPY | 5.24% |
| 2011 Q1 | -267.64 Million JPY | 0.57% |
| 2011 Q4 | -246.94 Million JPY | 13.29% |
| 2011 Q3 | -284.78 Million JPY | 4.11% |
| 2011 Q2 | -296.99 Million JPY | -10.97% |
| 2010 Q1 | -297.24 Million JPY | -13.54% |
| 2010 Q3 | -312.76 Million JPY | -12.6% |
| 2010 Q4 | -269.18 Million JPY | 13.93% |
| 2010 Q2 | -277.78 Million JPY | 6.55% |
| 2010 FY | -1.15 Billion JPY | -5.19% |
| 2009 FY | -1.09 Billion JPY | 3.0% |
| 2009 Q3 | -264.76 Million JPY | 1.59% |
| 2009 Q2 | -269.03 Million JPY | 11.59% |
| 2009 Q1 | -304.3 Million JPY | -15.43% |
| 2009 Q4 | -261.8 Million JPY | 1.12% |
| 2008 FY | -1.13 Billion JPY | -4.4% |
| 2008 Q3 | -282.12 Million JPY | -0.23% |
| 2008 Q2 | -281.46 Million JPY | 8.25% |
| 2008 Q1 | -306.76 Million JPY | 0.0% |
| 2008 Q4 | -263.62 Million JPY | 6.56% |
| 2007 FY | -1.08 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 62.716% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | 127.171% |
| GNI Group Ltd. | 8.09 Billion JPY | 98.231% |
| Linical Co., Ltd. | 338.26 Million JPY | 57.676% |
| Trans Genic Inc. | 4.08 Million JPY | -3404.749% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 109.956% |
| Soiken Holdings Inc. | -662.2 Million JPY | 121.62% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | -3.629% |
| AnGes, Inc. | -7.43 Billion JPY | 101.925% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 111.114% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 101.99% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 23.314% |
| NanoCarrier Co., Ltd. | -780 Million JPY | 118.355% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 112.418% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 111.842% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | 117.623% |
| RaQualia Pharma Inc. | -323.66 Million JPY | 144.234% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 111.735% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 110.068% |
| PeptiDream Inc. | 3.03 Billion JPY | 95.284% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 107.386% |
| Ribomic Inc. | -1.02 Billion JPY | 113.978% |
| SanBio Company Limited | -2.64 Billion JPY | 105.415% |
| Healios K.K. | -3.82 Billion JPY | 103.745% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 112.257% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 109.611% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 110.016% |
| StemRIM | -2.02 Billion JPY | 107.081% |
| CellSource Co., Ltd. | 923.14 Million JPY | 84.491% |
| FunPep Company Limited | -933.41 Million JPY | 115.338% |
| Kringle Pharma, Inc. | -854.15 Million JPY | 116.762% |
| Stella Pharma Corporation | -763.74 Million JPY | 118.746% |
| TMS Co., Ltd. | -960.04 Million JPY | 114.913% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 112.67% |
| Cuorips Inc. | -632.18 Million JPY | 122.647% |
| K Pharma,Inc. | 260.33 Million JPY | 45.005% |
| Takara Bio Inc. | 1.48 Billion JPY | 90.326% |
| ReproCELL Incorporated | -31.41 Million JPY | 555.735% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | -442.759% |
| StemCell Institute Inc. | 310.98 Million JPY | 53.962% |
| CellSeed Inc. | -846.53 Million JPY | 116.912% |